Catalyst Wire Dossier Catalyst Wire Dossier

Bovine Milk Immunoglobulin Against CS17 and CsbD

bovine milk immunoglobulin · Johns Hopkins Bloomberg School of Public Health
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bovine Milk Immunoglobulin Against CS17 and CsbD, covering 2017-04-05 to 2017-04-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Bovine Milk Immunoglobulin Against CS17 and CsbD [Phase 2]

See pricing